Vimarsana
Biggest News Aggregation in the World

Page 5 - Life Sciences Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Life Sciences Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Life Sciences Group Today - Breaking & Trending Today

FDA Grants Fast Track Designation to SLS009 for Relapsed/Refractory PTCL - Vimarsana News

FDA Grants Fast Track Designation to SLS009 for Relapsed/Refractory PTCL

The FDA has granted a fast track designation to SLS009 for the treatment of patients with relapsed/refractory peripheral T-cell lymphoma.

SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) Sees Large Growth in Short Interest - Vimarsana News

SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) Sees Large Growth in Short Interest

SELLAS Life Sciences Group, Inc. (NASDAQ:SLS – Get Free Report) was the target of a significant growth in short interest in October. As of October 15th, there was short interest totalling 2,040,000 shares, a growth of 87.2% from the September 30th total of 1,090,000 shares. Based on an average trading volume of 314,700 shares, the […]

FDA Awards Orphan Drug Designation to SLS009 in AML - Vimarsana News

FDA Awards Orphan Drug Designation to SLS009 in AML

The FDA has granted an orphan drug designation to SLS009 for the treatment of patients with acute myeloid leukemia.

Sellas Life Sciences Group Gets FDA Orphan Drug Designation to Treat Type of Leukemia - Vimarsana News

Sellas Life Sciences Group Gets FDA Orphan Drug Designation to Treat Type of Leukemia

By Sabela Ojea Sellas Life Sciences Group said it received an orphan drug designation from the U.S. Food and Drug Administration to treat acute myeloid...

Sellas Life Sciences Group Gets FDA Orphan Drug Designation to Treat Type of Leukemia - Vimarsana News

Sellas Life Sciences Group Gets FDA Orphan Drug Designation to Treat Type of Leukemia

By Sabela Ojea Sellas Life Sciences Group said it received an orphan drug designation from the U.S. Food and Drug Administration to treat acute myeloid leukemia. The clinical...